10:54 AM EDT, 10/01/2024 (MT Newswires) -- Codexis ( CDXS ) said Tuesday it has signed a non-exclusive commercial and manufacturing license agreement with Alphazyme, part of Maravai LifeSciences ( MRVI ) , covering multiple enzymes from Codexis' ( CDXS ) life science enzyme portfolio.

The agreement includes licenses for the HiFi DNA Polymerase, HiTemp Reverse Transcriptase, HiRev Isothermal Polymerase and other enzymes previously directed towards genomics and diagnostics.

Codexis ( CDXS ) will receive sales-based royalties under the terms of the agreement, according to the company.

Price: 3.05, Change: -0.03, Percent Change: -0.97